Headquarters: Watertown, Massachusetts, United States
Trade prices
Volume:2.3M
Market Cap:18.33M
Prev closed:2.31
Open:2.19
High:2.27
Low:2.18
52 week low:0.56
52 week high:16.2
Dividends:No Dividends
Next ER:August 6, 2020 After Market Closes
Top Stories (TTPH)
Company Profile
According to The Review on Antimicrobial Resistance (May 2016), by 2050, antimicrobial resistance is projected to kill more people than cancer and diabetes combined. At Tetraphase, the fight against antimicrobial resistance is at the core of who we are as a company.
Talk about Tetraphase Pharmaceuticals, Inc. below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.
